Back to Search Start Over

MLN4924 therapy as a novel approach in cancer treatment modalities.

Authors :
Oladghaffari M
Islamian JP
Baradaran B
Monfared AS
Source :
Journal of chemotherapy (Florence, Italy) [J Chemother] 2016 Apr; Vol. 28 (2), pp. 74-82.
Publication Year :
2016

Abstract

MLN4924 is an investigational and a newly discovered small molecule that is a potent and selective inhibitor of the NEDD8 (Neural precursor cell-Expressed Developmentally down-regulated 8) Activating Enzyme (NAE), a pivotal regulator of the Cullin Ring Ligases E3 (CRL), which has been implicated recently in DNA damage. MLN4924 effectively inhibits tumour cell growth by inducing all three common types of death, namely apoptosis, autophagy and senescence and it was also reported that the formation of capillary vessels was significantly suppressed by MLN4924.In this review, we are going to highlight the molecular mechanism of MLN4924 in cancer therapy and its pros and cons in cancer therapy.

Details

Language :
English
ISSN :
1973-9478
Volume :
28
Issue :
2
Database :
MEDLINE
Journal :
Journal of chemotherapy (Florence, Italy)
Publication Type :
Academic Journal
Accession number :
26292710
Full Text :
https://doi.org/10.1179/1973947815Y.0000000066